Reference:
Sadaghianloo, N., Jean-Baptiste, E., Islam, M.S., Dardik, A., Declemy, S. and Hassen-Khodja, R. (2015) Vascular Access Thrombosis in France: Incidence and Treatment Patterns. Annals of Vascular Surgery. May 21st. [epub ahead of print].
[ctt tweet=”Review of vascular access related thrombosis in France http://ctt.ec/2e9e1+ @ivteam #ivteam” coverup=”2e9e1″]
Abstract:
INTRODUCTION: Vascular access thrombosis lacks the implementation of a treatment algorithm at large scale, involving all the actors. We aimed to determine a better understanding of the current practice patterns around vascular access thrombosis in France, with 4 axes: incidence, surveillance protocol, treatment, and time to treatment.
MATERIAL AND METHODS: A comprehensive survey of all the nephrologists staffing all hemodialysis centers in France during April 2013 included 266 of 269 (99%) centers, treating 27798 patients with arteriovenous fistula or graft.
RESULTS: In 104 centers treating 11088 patients, there were 905 documented episodes of vascular access thrombosis (8.8%) in 1 year; in the other 162 centers that supplied a range of events, the mean incidence was 8.4%. Use of in-line access flow monitoring as part of surveillance program was not correlated with better outcome compared to Doppler ultrasound (thrombosis: 7,9% vs. 10%, respectively, P=.09). 53% of centers referred the patients to a vascular surgeon and 32% to an interventional radiologist (2% to urologist, 13% variable referral depending on case complexity). Time to treatment was 48h (9%) occurred mainly in rural zones (P=.04). The specialty of the treating physician did not influence time to treatment (P>.05).
CONCLUSION: In France, vascular access thrombosis rate is low, and not influenced by surveillance protocol type. Most patients can receive timely treatment by vascular surgeons or interventional radiologists.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]